HTG Molecular Diagnostics Overview
Contact top employees from
HTG Molecular Diagnostics
Summary
HTG Molecular Diagnostics is a public company that has been in the industry for 28 years. The company currently specializes in the Biotechnology, Health Care Technology areas. The position of the President & CEO is occupied by John L. Lubniewski. Its headquarters is located at Tucson, Arizona, USA. The number of employees ranges from 25 to 100. The annual revenue of HTG Molecular Diagnostics varies between 5.0M and 25M. Total funding of the company - $171.5M. To connect with HTG Molecular Diagnostics employee register on SignalHire.
HTG Molecular Diagnostics industries
Biotechnology
Headquarters Location
HTG Molecular Diagnostics Employees Size
100-200 employees
Specialties
RNA Analysis, Companion Diagnostics, Molecular Diagnostics, Pharma Services, mRNA, miRNA, Sequencing, Gene Expression
SIC Code
8090
DMA Code
Sierra Vista-douglas Metropolitan Area
Founded
1997
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Contact HTG Molecular Diagnostics
Organization Website
Social Links
Contact Email
info@htgmolecular.com
Phone Number
18772892615
HTG Molecular Diagnostics Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2008 | Privately Held | 25 - 100 | 14.2M | $89.1M | |
| 1998 | Privately Held | 25 - 100 | 15.7M | $6.1M | |
| 2008 | Privately Held | 25 - 100 | 7.5M | $150M | |
| 2001 | Privately Held | 25 - 100 | 15M | $73.8M | |
| 2003 | Privately Held | 25 - 100 | 6.1M | $32.4M | |
| 2013 | Privately Held | 1 - 25 | 4M | $22.5M | |
| 1998 | Public Company | 5.0K - 10K | 4B | $96M | |
| 2008 | Privately Held | 100 - 250 | 33M | $32M | |
| 1990 | Privately Held | 1.0K - 5.0K | 1.3B | $70M | |
| 2013 | Privately Held | 250 - 500 | 50.5M | $175.1M | |
| 1999 | Public Company | 10K - 50K | 5.3B | $2.2B | |
| 1970 | Privately Held | 250 - 500 | 80M | $5M | |
| 2006 | Privately Held | 25 - 100 | 6.3M | $2.7M | |
| 2013 | Partnership | 100-200 | < 1M | $150K | |
| 2006 | Privately Held | 100 - 250 | 4M | $0 | |
| 1952 | Public Company | 5.0K - 10K | 2.9B | $0 | |
| 1984 | - | 10000+ | - | $- | |
| 1974 | - | 500-1000 | - | $- | |
| 1896 | - | 10000+ | - | $- | |
| - | - | 10-50 | - | $- |
HTG Molecular Diagnostics Revenue
Annual Revenue
7.9M
Revenue dynamics are not stable. Noticeable growth in Q4 2020 was replaced by significant decline in Q1 2021. Revenue then showed substantial growth again in Q2 2021. As a result, the company's quarterly revenue increased by 297.1K - from 1.8M in Q3 2020 to 2.1M in Q2 2021.HTG Molecular Diagnostics Funding
By Q2 2020, HTG Molecular Diagnostics has participated in at least 10 funding rounds and has raised a minimum of 171.5M. Funding increased noticeable in Q2 2020 — by 8.3M compared to the previous Q3 2019. HTG Molecular Diagnostics raised the least in Q2 2011 at 500.0K, while the most successful funding round in Q1 2018 raised 70.4M.
HTG Molecular Diagnostics Employees Turnover 2 quarter 2025
Contact top employees from
HTG Molecular Diagnostics
Stephen Barat
SVP, Executive Officer and Therapeutics Division Head
Mathew Morrissette
Operations Process Engineer
Sandy Shaeffer
HR Administrator
Ian Howlett
Scientist, Scientific Services
Patrick Roche
Sr Vice President
Deb Gordon
Chief Legal Counsel
Cassie Chen
Bioinformatics
Kurt Michels
Data Scientist
Scott Wernersbach
Business Development Manager
Tristin Martin
Senior Manager, Project Management
Ann Hanham
Board Member
Lewis Shuster
Board Member
Jeffrey Matthews
Lab Technician
Tyler Lehane
Data Scientist
Tiffany Vines
Head of North America Pharma Sales
Jeff Whitty
Director of Scientific Collaborations
Krista Jacobson
Director, VERI/O Laboratory
Alexandra Ulbrich
Office Temporary
Baerbel Babs Gearheart
Staff Accountant
Michael Ball
Field Service Specialist
Clifford Chen
Reagent Team Lead
Stephen Bingham
Manager, Data Systems
Gregory Reinholz
Senior Staff Scientist, Therapeutics
